Developing mechanistic understanding of unconventional growth in pharmaceutical crystals using scanning electron microscopy, atomic force microscopy and time-of-flight secondary ion mass spectrometry
Hector Polyzois(Engineering and Physical Sciences Research Council), Alastair J. Florence(University of Strathclyde), Deborah Bowering(University of Strathclyde), Sarah L. Price(University College London), Rui Guo(Pfizer (United States)), Gavin Halbert(University of Strathclyde), Eleonora Paladino(University of Strathclyde), Monika Warzecha(University of Strathclyde)
Unknown
October 16, 2019
Cited by 0
Related Papers
Report on the sixth blind test of organic crystal structure prediction methods
|Acta Crystallographica Section B Structural Science Crystal Engineering and Materials|2016|606
Indole-3-Acetic Acid Biosynthesis Pathways in the Plant-Beneficial Bacterium Arthrobacter pascens ZZ21
|International Journal of Molecular Sciences|2018|139
Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice
|Journal of Pharmaceutical Sciences|2017|138
Successful Computationally Directed Templating of Metastable Pharmaceutical Polymorphs
|Crystal Growth & Design|2018|79